Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Genta, Inc. (GNTA) -- Ignore unavailable to you. Want to Upgrade?

To: ptlusa who wrote (1861)	1/27/2007 5:56:06 PM
From: ptlusa	Read Replies (1) \| Respond to of 1870

email said there was some big money news on this one i think there may be something hot here. maybe acqusition interest? ===== For God so loved the world, that he gave his only begotten Son, that whosoever believeth on him should not perish, but have everlasting life

To: ptlusa who wrote (1861)	1/27/2007 9:57:06 PM
From: Art Bechhoefer	Read Replies (2) \| Respond to of 1870

We're still waiting for word on what the European regulators decide regarding Genasense combined with existing chemo drugs for treating melanoma. Also a similar application is being considered in Australia. My own view is that (1) the Genta people don't have very good help preparing an application for review, and especially in the area of statistical analysis. And (2) many of the key people at Genta have been working on Genasense for a long enough time to know that it works and is worth pursuing. Otherwise, why would anyone stay around five or six years, or even longer, if there wasn't a pretty good chance of a successful outcome? One of the reasons they chose to study Genasense for treating leukemia was that the type of leukemia being treated is almost always fatal. Therefore, one would think that a successful test would show more survivors than expected. Unfortunately, you can have samples where the patients are so far gone that treatment with any medication can't change the result. Remember that a lot of the patients already had undergone unsuccessful treatment with other drugs, and their conditions were getting worse and worse. Art